Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer [Phase 3]
Phase 3 trial comparing Keyhole limpet hemocyanin with doxorubicin in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Paclitaxel in Treating Patients With Early-Stage Bladder Cancer [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluating paclitaxel for early-stage bladder cancer have been completed.
-
CLINICAL_TRIALS research · 2013-05-06Clinical Trial Update: Comparison of Two Insertion Technique of I-gel [NA]
This document provides an update on a clinical trial comparing two insertion techniques for the I-gel airway device. The study involves pati…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating trastuzumab for previously treated, locally advanced or metastatic urothelial cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection [NA]
A completed clinical trial evaluating the Loop Resectoscope for treating bladder cancer in patients undergoing transurethral resection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-03-25Clinical Trial Update: The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel
This clinical trial update investigates whether alpha-1 acid glycoprotein levels are associated with outcomes in metastatic cancer patients …
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Pazopanib in Treating Patients With Metastatic Urothelial Cancer [Phase 2]
A Phase 2 trial of pazopanib in metastatic urothelial cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Endoscopic Subsurface Optical Imaging for Cancer Detection
This clinical trial update reports the completion of a study on Endoscopic Subsurface Optical Imaging for Cancer Detection conducted by the …
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer [NA]
A clinical trial evaluating neoadjuvant chemotherapy for locally advanced bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Celecoxib in Treating Patients With Bladder Cancer [Phase 2, Phase 3]
Celecoxib is being studied in Phase 2 and Phase 3 trials for recurrent bladder cancer. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Duke Urology Database and Specimen Bank
This update notes the completion of the Duke Urology Database and Specimen Bank clinical trial (NCT00978991) sponsored by Duke University, i…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Decitabine in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports the completion of a Phase 1 trial of decitabine in patients with advanced solid tumors, including breast, bladder, and m…
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer [Phase 2]
A Phase 2 study evaluating the combination of Bacillus Calmette-Guérin (BCG) with interferon alfa-2b for bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer [Phase 2]
A Phase 2 trial evaluated AD-32 with or without BCG after surgery in patients with newly diagnosed or recurrent superficial bladder cancer. …
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium [Phase 2]
Phase 2 trial update of S0121 evaluating neoadjuvant carboplatin, paclitaxel, and gemcitabine followed by cisplatin and radiation for locall…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking [Phase 4]
Phase 4 clinical trial results on counseling and nicotine replacement therapy to help adult smokers quit, including participants with variou…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Gene Therapy in Treating Patients With Advanced Bladder Cancer [Phase 1]
Phase 1 gene therapy trial update for advanced bladder cancer has completed, including patients with recurrent and various stages of the dis…
-
CLINICAL_TRIALS withdrawal · 2013-01-17Clinical Trial Update: Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer [Phase 2]
A Phase 2 trial of lapatinib plus weekly paclitaxel for advanced urothelial cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy [EARLY_Phase 1]
Phase 0 neoadjuvant trial of lapatinib for infiltrative bladder cancer before cystectomy; the study sponsored by University Hospital, Bordea…
-
FDA approval · 2012-12-20FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for VALSTAR (valrubicin) from Endo USA, Inc., supporting updated labeling and/or indications for int…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin [Phase 2]
Phase 2 clinical trial evaluating gemcitabine for recurrent bladder cancer that did not respond to BCG; trial completed with results posted …
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Perioperative Outcome in Patients Undergoing Radical Cystectomy [NA]
A completed clinical trial evaluated whether noradrenaline administration combined with restrictive intraoperative fluid substitution affect…